Early safety check for new drug MT-6345 in healthy people
NCT ID NCT03809039
First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 24 times
Summary
This early-stage study tested the safety and how the body handles a new drug called MT-6345 in 52 healthy adults. The goal was to see what side effects occur and how the drug moves through the body. Since it was only a safety study in healthy people, there was no treatment for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational center
City Name, United Kingdom
Conditions
Explore the condition pages connected to this study.